International University Of Health And Welfare
Clinical trials sponsored by International University Of Health And Welfare, explained in plain language.
-
New hope for Hard-to-Treat lung condition: satralizumab trial targets inflammation
Disease control CompletedThis Phase 2 trial tests whether satralizumab, an antibody that blocks IL-6 (a protein involved in inflammation), can improve blood flow in the lungs of people with pulmonary arterial hypertension (PAH). The study includes 20 adults in Japan who have high IL-6 levels and haven't …
Phase: PHASE2 • Sponsor: International University of Health and Welfare • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Cancer pain relief without the sickness: new hope from an old drug
Symptom relief CompletedThis study tested whether naldemedine, a drug already used for opioid-induced constipation, can also prevent nausea and vomiting when cancer patients start strong painkillers. 120 adults with cancer who were beginning opioid therapy took either naldemedine or a placebo for up to …
Phase: PHASE4 • Sponsor: International University of Health and Welfare • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC